IL26 and myeloid sarcoma: Seroreactivity elicited by IL-26–20KK was higher in the MS group compared to healthy subjects reaching 58.33% of patients whose autoreactive Abs exceeded positivity threshold, while elevated responses against IL-256–70 were registered in 43.52% of MS individuals (Figure 1).